Gradient Denervation Technologies

Manufacturing · France · 1-10 Employees

View Company Info for Free

Overview

Headquarters

9 Rue D'enghien, Paris, Ile-de-France, 7...

Revenue

<$5 Million

Industry

Manufacturing Medical Devices & Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Gradient Denervation Technologies

Gradient Denervation Technologies is a Paris-based medical device company focused on developing a minimally invasive, ultrasound-based system for treating pulmonary hypertension, particularly in patients with left-sided heart disease. Their innovative Gradient Denervation System utilizes therapeutic ultrasound energy to ablate nerves around the pulmonary artery, addressing a significant clinical need in a patient population with limited treatment options. The company leverages intellectual property developed at Stanford University and aims to transform the treatment landscape for pulmonary hypertension. Their target clients include healthcare providers and patients suffering from pulmonary hypertension due to heart failure.Explore more
Gradient Denervation Technologies's Social MediaPopular SearchesGradient Denervation TechnologiesSIC Code 38,384NAICS Code 33,339Show more

Gradient Denervation Technologies Org Chart

PhoneEmail
GM
France flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Gradient Denervation Technologies your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Gradient Denervation Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Gradient Denervation Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gradient Denervation Technologies.

Gradient Denervation Technologies financials insights

Gather financial insights about Gradient Denervation Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2023

Series A

$15M

See All Gradient Denervation Technologies's Financials Insights

Gradient Denervation Technologies Tech Stack

A closer look at the technologies used by Gradient Denervation Technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Gradient Denervation Technologies

What is Gradient Denervation Technologies's official website?
Gradient Denervation Technologies's official website is www.gradientdenervation.com
What is Gradient Denervation Technologies's Revenue?
Gradient Denervation Technologies's revenue is <$5 Million
What is Gradient Denervation Technologies's SIC code?
Gradient Denervation Technologies's SIC: 38,384
What is Gradient Denervation Technologies's NAICS code?
Gradient Denervation Technologies's NAICS: 33,339
How many employees does Gradient Denervation Technologies have?
Gradient Denervation Technologies has 1-10 employees
What industry does Gradient Denervation Technologies belong to?
Gradient Denervation Technologies is in the industry of: Manufacturing, Medical Devices & Equipment
What technology does Gradient Denervation Technologies use?
Some of the popular technologies that Gradient Denervation Technologies uses are: WordPress.org, PHP, Cloudflare CDN, Adobe Typekit
Who is the CFO of Gradient Denervation Technologies?
Gradient Denervation Technologies's CFO is Greg Mann
What does Gradient Denervation Technologies do?

Gradient Denervation Technologies is a Paris-based medical device company focused on developing a minimally invasive, ultrasound-based system for treating pulmonary hypertension, particularly in patients with left-sided heart disease. Their innovative Gradient Denervation System utilizes therapeutic ultrasound energy to ablate nerves around the pul... monary artery, addressing a significant clinical need in a patient population with limited treatment options. The company leverages intellectual property developed at Stanford University and aims to transform the treatment landscape for pulmonary hypertension. Their target clients include healthcare providers and patients suffering from pulmonary hypertension due to heart failure.Read More

What are Gradient Denervation Technologies social media links?
Gradient Denervation Technologies Linkedin page Gradient Denervation Technologies Twitter page Gradient Denervation Technologies Facebook page
Who invested in Gradient Denervation Technologies?
Gradient Denervation Technologies has 3 investors including Thuja Capital, Sofinnova Partners and Asabys Partners.
Is Gradient Denervation Technologies a public company?
Gradient Denervation Technologies is private company therefore does not currently have an official ticker symbol
See more information about Gradient Denervation Technologies

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.